depression Archives

News and Trends 21 Mar 2025

Depression drug trials are failing—and placebos are to blame

In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research.

March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter

Trump’s healthcare cabinet picks: Implications for U.S. biopharma

News and Trends 29 Nov 2024

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.?

November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

In Depth 13 May 2024

New antidepressants: tackling treatment resistant depression

Take a look at how new antidepressants can more effectively tackle treatment resistant depression compared to more traditional treatments.

May 13, 2024 - 11 minutesmins - By Willow Shah-Neville

In Depth 13 Mar 2024

From LSD to healing minds: Where are we standing in psychedelic drug development?

Delve into the growing sector of psychedelic drug development to find out where we are coming from, and where we are standing in the field.

March 13, 2024 - 13 minutesmins - By Jules Adam

Best in Biotech 17 Aug 2023

Six Toronto-based biotech companies to watch this year

The capital city of the Canadian province of Ontario, Toronto, is home to the Discovery District, a commercial hub that sees biotech and healthcare innovations and companies at its prime. Having witnessed the largest growth in tech jobs in North America between 2015 and 2020, Toronto, like Vancouver, is a significant contributor towards Canada’s life […]

August 17, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 23 Feb 2023

Depression trial gets green light

Beckley Psytech Ltd has received investigational new drug (IND) approval from the U.S. Food and Drug Administration (FDA) for a global multi-site phase IIb study exploring the safety, efficacy and tolerability of two doses of its lead compound, BPL–003, in patients with treatment resistant depression (TRD). BPL-003 is the Beckley Psytech’s novel synthetic formulation of […]

February 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 15 Nov 2022

Potential new lead compounds for treatment of depression and anxiety disorders

Currently, various classes of drugs are available for the treatment of mental illnesses – such as depression and anxiety disorders. However, although these drugs have benefits, they can also be associated with adverse side-effects. A research group has conducted a study to identify new drugs that could potentially be used for the treatment of neuropsychiatric […]

November 15, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 15 Nov 2022

Beckley Psytech completes treatment resistant depression and alcohol use disorder study

Beckley Psytech, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medicines, has completed its phase I clinical study of BPL-003, a synthetic intranasal formulation of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT), which is under development for treatment resistant depression and alcohol use disorder. The double-blind, randomized, single ascending dose study […]

November 15, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 24 Oct 2022

Beckley Psytech acquires Eleusis Therapeutics

Beckley Psytech Limited has entered into a definitive agreement to acquire clinical-stage life science company Eleusis Therapeutics Limited in an all equity transaction. Under the terms of the agreement, which has been approved by shareholders, Beckley Psytech has acquired 100% of Eleusis, receiving full developmental and commercial rights for the company’s assets, which will further […]

October 24, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 19 Aug 2022

Axsome Therapeutics’ MDD treatment gets green light from FDA

The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics, Inc.’s Auvelity tablets for the treatment of major depressive disorder (MDD) in adults. Auvelity (dextromethorphan HBr -bupropion HCl) is the first and only rapid-acting oral medicine approved for the treatment of MDD with labeling of statistically significant antidepressant efficacy compared to placebo starting at […]

August 19, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 15 Aug 2022

Approval for Small Pharma major depressive disorder clinical trial

Small Pharma Inc. has received approval from the U.K. Medicines and Healthcare products Regulatory Authority (MHRA) and the Regional Ethics Committee to initiate a drug interaction clinical trial in the U.K. The clinical trial will assess the interaction between serotonin reuptake inhibitors (SSRIs) and SPL026, the company’s lead N, N-dimethyltryptamine (DMT) candidate, in patients with […]

August 15, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 9 Aug 2022

Relmada Therapeutics gets Fast Track designation for major depressive disorder treatment

Relmada Therapeutics, Inc., a late-stage biotech company addressing diseases of the central nervous system (CNS), has been given U.S. Food and Drug Administration (FDA) Fast Track designation to REL-1017, the company’s novel NMDA receptor (NMDAR) channel blocker, as a monotherapy for the treatment of major depressive disorder (MDD). “The receipt of Fast Track Designation represents […]

August 9, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

depression

Depression drug trials are failing—and placebos are to blame

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

New antidepressants: tackling treatment resistant depression

From LSD to healing minds: Where are we standing in psychedelic drug development?

Six Toronto-based biotech companies to watch this year

Depression trial gets green light

Potential new lead compounds for treatment of depression and anxiety disorders

Beckley Psytech completes treatment resistant depression and alcohol use disorder study

Beckley Psytech acquires Eleusis Therapeutics

Axsome Therapeutics’ MDD treatment gets green light from FDA

Approval for Small Pharma major depressive disorder clinical trial

Relmada Therapeutics gets Fast Track designation for major depressive disorder treatment

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!